1. Involvement of Ca2+ in the inhibition by crocetin of angiotensin II-induced ERK1/2 activation in vascular smooth muscle cells.
- Author
-
Zhou CH, Qian ZY, Xiang M, and He SY
- Subjects
- Animals, Animals, Newborn, Calcium pharmacokinetics, Calcium physiology, Calcium Channel Blockers pharmacology, Cattle, Cells, Cultured, Chelating Agents pharmacology, Dose-Response Relationship, Drug, Egtazic Acid pharmacology, Enzyme Activation drug effects, Intracellular Fluid drug effects, Intracellular Fluid metabolism, Muscle, Smooth, Vascular cytology, Muscle, Smooth, Vascular metabolism, Myocytes, Smooth Muscle cytology, Myocytes, Smooth Muscle drug effects, Myocytes, Smooth Muscle metabolism, Time Factors, Verapamil pharmacology, Vitamin A analogs & derivatives, Angiotensin II pharmacology, Calcium metabolism, Carotenoids pharmacology, Mitogen-Activated Protein Kinase 1 metabolism, Mitogen-Activated Protein Kinase 3 metabolism, Muscle, Smooth, Vascular drug effects
- Abstract
Crocetin, a carotenoid compound, was isolated from Gardenia jasminoids Ellis. Our recent study shows that crocetin inhibits angiotensin II-induced extracellular signal-regulated kinases 1/2 (ERK1/2) activation and subsequent proliferation in vascular smooth muscle cells (VSMCs). To further explore the mechanism involved, in the present study, we investigated the effect of Ca(2+) in the activation of ERK1/2 and whether Ca(2+) is involved in the suppression by crocetin of angiotensin II-induced ERK1/2 activation. Our findings showed that crocetin pretreatment partially attenuated both the intracellular Ca(2+) mobilization and the extracellular Ca(2+) influx induced by angiotensin II. Moreover, angiotensin II-induced ERK1/2 activation was completely abolished by acetoxymethyl ester of 1,2-bis(2-aminophenoxy)ethane-N,N,N ',N'-tetraacetic acid (BAPTA-AM), an intracellular Ca(2+) chelator, and partially inhibited by EGTA, an extracellular Ca(2+) chelator, or verapamil, an L-type Ca(2+) channel blocker. These findings suggest that Ca(2+) may play an important role in angiotensin II-induced ERK1/2 activation in VSMCs, and Ca(2+)-dependent pathway may be involved in the inhibitory effect by crocetin of angiotensin II-induced ERK1/2 activation.
- Published
- 2007
- Full Text
- View/download PDF